Medicare could and should have saved over $20 million in payments for medically unnecessary LDL cholesterol blood tests if CMS hadn’t been asleep at the wheel for the past five years. That’s the gist of the message of a new OIG report that compliance managers need to know about, especially if their labs provide such…
OIG Sounds the Alarm on Improper Billing of Lipid Panels & Direct HDL Tests
